289 related articles for article (PubMed ID: 29861526)
1. Levetiracetam use during pregnancy in women with epilepsy: Preliminary observations from a tertiary care center in Northern India.
Bansal R; Suri V; Chopra S; Aggarwal N; Sikka P; Saha SC; Goyal MK; Kumar P
Indian J Pharmacol; 2018; 50(1):39-43. PubMed ID: 29861526
[TBL] [Abstract][Full Text] [Related]
2. Monotherapy treatment of epilepsy in pregnancy: congenital malformation outcomes in the child.
Weston J; Bromley R; Jackson CF; Adab N; Clayton-Smith J; Greenhalgh J; Hounsome J; McKay AJ; Tudur Smith C; Marson AG
Cochrane Database Syst Rev; 2016 Nov; 11(11):CD010224. PubMed ID: 27819746
[TBL] [Abstract][Full Text] [Related]
3. Comparative study of antiepileptic drug use during pregnancy over a period of 12 years in Spain. Efficacy of the newer antiepileptic drugs lamotrigine, levetiracetam, and oxcarbazepine.
Martinez Ferri M; Peña Mayor P; Perez López-Fraile I; Escartin Siquier A; Martin Moro M; Forcadas Berdusan M;
Neurologia (Engl Ed); 2018 Mar; 33(2):78-84. PubMed ID: 27452623
[TBL] [Abstract][Full Text] [Related]
4. Behavioral effects and somnolence due to levetiracetam versus oxcarbazepine - a retrospective comparison study of North Indian patients with refractory epilepsy.
Shukla G; Gupta A; Agarwal P; Poornima S
Epilepsy Behav; 2016 Nov; 64(Pt A):216-218. PubMed ID: 27756024
[TBL] [Abstract][Full Text] [Related]
5. Change in antiepileptic drug prescription patterns for pregnant women with epilepsy over the years: Impact on pregnancy and fetal outcomes.
Bansal R; Suri V; Chopra S; Aggarwal N; Sikka P; Saha SC; Kharbanda PS; Kumar P
Indian J Pharmacol; 2019; 51(2):93-97. PubMed ID: 31142944
[TBL] [Abstract][Full Text] [Related]
6. Child development following in utero exposure: levetiracetam vs sodium valproate.
Shallcross R; Bromley RL; Irwin B; Bonnett LJ; Morrow J; Baker GA; ;
Neurology; 2011 Jan; 76(4):383-9. PubMed ID: 21263139
[TBL] [Abstract][Full Text] [Related]
7. Levetiracetam Use During Pregnancy in Women With Active Epilepsy: A Hospital-Based, Retrospective Study from a Tertiary Care Hospital in North Eastern INDIA.
Sharma SR; Sharma N; Hussain M; Mobing H; Hynniewta Y
Neurol India; 2021; 69(3):692-697. PubMed ID: 34169870
[TBL] [Abstract][Full Text] [Related]
8. Obstetric outcomes and effects on babies born to women treated for epilepsy during pregnancy in a resource limited setting: a comparative cohort study.
Galappatthy P; Liyanage CK; Lucas MN; Jayasekara DTLM; Abhayaratna SA; Weeraratne C; De Abrew K; Gunaratne PS; Gamage R; Wijeyaratne CN
BMC Pregnancy Childbirth; 2018 Jun; 18(1):230. PubMed ID: 29898689
[TBL] [Abstract][Full Text] [Related]
9. Antiepileptic drug clearance and seizure frequency during pregnancy in women with epilepsy.
Reisinger TL; Newman M; Loring DW; Pennell PB; Meador KJ
Epilepsy Behav; 2013 Oct; 29(1):13-8. PubMed ID: 23911354
[TBL] [Abstract][Full Text] [Related]
10. Impact of planning of pregnancy in women with epilepsy on seizure control during pregnancy and on maternal and neonatal outcomes.
Abe K; Hamada H; Yamada T; Obata-Yasuoka M; Minakami H; Yoshikawa H
Seizure; 2014 Feb; 23(2):112-6. PubMed ID: 24183922
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of levetiracetam during pregnancy, delivery, in the neonatal period, and lactation.
Tomson T; Palm R; Källén K; Ben-Menachem E; Söderfeldt B; Danielsson B; Johansson R; Luef G; Ohman I
Epilepsia; 2007 Jun; 48(6):1111-6. PubMed ID: 17381438
[TBL] [Abstract][Full Text] [Related]
12. The treatment of neonatal seizures: focus on Levetiracetam.
Loiacono G; Masci M; Zaccara G; Verrotti A
J Matern Fetal Neonatal Med; 2016; 29(1):69-74. PubMed ID: 25385270
[TBL] [Abstract][Full Text] [Related]
13. [Efficacy and safety of levetiracetam (keppra) add-on treatment in adult patients with refractory epilepsy in two tertiary centers].
Auriel E; Chistik V; Blatt I; Margolin N; Neufeld M
Harefuah; 2007 Apr; 146(4):269-71, 318. PubMed ID: 17476932
[TBL] [Abstract][Full Text] [Related]
14. Long-lasting antiepileptic effects of levetiracetam against epileptic seizures in the spontaneously epileptic rat (SER): differentiation of levetiracetam from conventional antiepileptic drugs.
Ji-qun C; Ishihara K; Nagayama T; Serikawa T; Sasa M
Epilepsia; 2005 Sep; 46(9):1362-70. PubMed ID: 16146430
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and tolerability of levetiracetam versus phenytoin after supratentorial neurosurgery.
Milligan TA; Hurwitz S; Bromfield EB
Neurology; 2008 Aug; 71(9):665-9. PubMed ID: 18725591
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological outcomes in juvenile myoclonic epilepsy: Support for sodium valproate.
Chowdhury A; Brodie MJ
Epilepsy Res; 2016 Jan; 119():62-6. PubMed ID: 26675554
[TBL] [Abstract][Full Text] [Related]
17. Measurement of levetiracetam drug levels to assist with seizure control and monitoring of drug interactions with other anti-epileptic medications (AEMs).
Stepanova D; Beran RG
Seizure; 2014 May; 23(5):371-6. PubMed ID: 24630809
[TBL] [Abstract][Full Text] [Related]
18. Pharmacodynamic and pharmacokinetic characterization of interactions between levetiracetam and numerous antiepileptic drugs in the mouse maximal electroshock seizure model: an isobolographic analysis.
Luszczki JJ; Andres MM; Czuczwar P; Cioczek-Czuczwar A; Ratnaraj N; Patsalos PN; Czuczwar SJ
Epilepsia; 2006 Jan; 47(1):10-20. PubMed ID: 16417526
[TBL] [Abstract][Full Text] [Related]
19. Levetiracetam and Valproate Retention Rate in Juvenile Myoclonic Epilepsy.
Sala-Padró J; Toledo M; Santamarina E; González-Cuevas M; Raspall-Chaure M; Sueiras-Gil M; Quintana M; Salas-Puig X
Clin Neuropharmacol; 2016; 39(6):299-301. PubMed ID: 27438183
[TBL] [Abstract][Full Text] [Related]
20. Lack of pharmacokinetic interaction of levetiracetam on carbamazepine, valproic acid, topiramate, and lamotrigine in children with epilepsy.
Otoul C; De Smedt H; Stockis A
Epilepsia; 2007 Nov; 48(11):2111-5. PubMed ID: 17651416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
